accountMarvelle Sullivan, the head of corporate legal M&A at Novartis AG (NYSE:NVS), spoke at The Deal Economy 2010...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICALS COMPANIES
The phrase "Big Pharma" is often used to refer to pharmaceutical companies with revenue in excess of $3 billion, and/or R&D expenditures in excess of $500 million. It is these pharmaceutical companies that are shaping the future of medicine. This topic covers the latest news and views on the companies behind the pharmaceuticals
10 largest are Johnson and Johnson, Pfizer, Bayer, GlaxoSmithKline, Novartis, Sanofi-Aventis, Hoffmann-La Roche, Astra Zeneca, Merck & Co., Abbott Laboratories.
Pharmaceuticals Companies is part of Business Exchange, suggested by
Henri TCHEN.
This topic contains
2,841 news
and
3,041 blog
items.
Read updated news, blogs, and resources about Pharmaceuticals Companies. Find user-submitted articles and reactions on Pharmaceuticals Companies from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Pfizer Inc. (NYSE:PFE) employees concerned about their jobs may have a better idea of where they stand.
When Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) bought Proteolix Inc. on Oct. 12, (The Deal Pipeline subscription...
Once a powerful profit-machine, big pharma is stumbling ,the threat of further government intervention, drying product...
Each year we come out with a list of companies who should get rid of their CEOs or which should make some strategic...
Johnson & Johnson (NYSE:JNJ), the world's biggest healthcare company that's been squeezed by generic competition,...
Since winning The Deal's Most Admired Corporate Dealmaker award in the healthcare category in 2008, Abbott Laboratories...
molecule type analysis 20 PharmaVitae Universe M&A analysis 23 PharmaVitae Universe operating performance analysis...
On Wednesday, Pfizer Inc. (NYSE:PFE) received approval from the FTC for its $68 billion acquisition of Wyeth.
Major trends with potentially far-reaching consequences for Big Pharma are underway that will likely influence drug...
AcelRx Pharmaceuticals has a handful of mid- and late-state clinical products in development, which would make this a...
Merck's decision to acquire Schering-Plough (SGP) for $41 billion will improve its bottom line over the next two to...
Oncology deals keep coming. A week and a half after Sanofi-Aventis SA (NYSE:SNY) acquired the rights to sell an...
The race to offer H1N1 flu vaccination is picking up pace. While global H1N1 vaccine manufacturers like Sanofi Pasteur,...
Threat of a pandemic triggered by a new swine flu strain will provide a windfall for some makers of drugs and vaccines.
‘No Frills Drugs’ push Pharmaceutical companies to look for a cure GSK, Bayer, AstraZeneca, Novartis and Mylan meet to...
We're tracking a subsector that's been hot with dealmaking -- oncology.
Ramius Capital Group's most recent portfolio holdings reveal that the hedge fund manager has shifted its portfolio...
WSJ.com is available in the following editions and languages:
The Royal College of Physicians is calling for an end to a 'culture' of doctors receiving freebies from pharmaceutical...
The swine flu outbreak is likely to benefit Kleiner Perkins Caufield & Byers because of the firm's portfolio of...
Cash starved companies are going to ... of bureaucratic big pharma processes that slow drug
Two days after Merck & Co announced a major push into generic versions of biotechnology medicines, Eli Lilly and Co...
Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's...
Top Sources: Pharmaceuticals Companies
- 247wallst.com
- Reuters
- online.wsj.com
- BusinessWeek
- World of DTC Marketing
- International Herald Tribune
- Mail Online UK
- New York Times
- industry.bnet.com
- phrma.org
Post a Job
Jobs in this Topic
Director, Business Development - Must have CNS, CRO exp
Pharmaceuticals Company
|
Hamilton, NJ
Posted: Oct 17
